|
Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 90 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012" provides data on the Anaplastic Astrocytoma clinical trial scenario. This report prov.....
Introduction GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2012" provides data on the Anaplastic Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 6 Introduction 7 Anaplastic Astrocytoma 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Anaplastic Astrocytoma 24 Subjects Recruited Over a Period of Time 26 Prominent Sponsors 27 Top Companies Participating in Anaplastic Astrocytoma Therapeutics Clinical Trials 29 Prominent Drug Comparison 31 Clinical Trial Profiles 32 Clinical Trial Overview of Top Companies 32 INSYS Therapeutics, Inc. 32 Clinical Trial Overview of INSYS Therapeutics, Inc. 32 Antisense Pharma GmbH 33 Clinical Trial Overview of Antisense Pharma GmbH 33 Tocagen Inc. 34 Clinical Trial Overview of Tocagen Inc. 34 Boneca Corporation 35 Clinical Trial Overview of Boneca Corporation 35 Advantagene, Inc. 36 Clinical Trial Overview of Advantagene, Inc. 36 Teva Pharmaceuticals USA, Inc. 37 Clinical Trial Overview of Teva Pharmaceuticals USA, Inc. 37 Light Sciences Oncology, Inc. 38 Clinical Trial Overview of Light Sciences Oncology, Inc. 38 Grifols, S.A. 39 Clinical Trial Overview of Grifols, S.A. 39 Merck & Co., Inc. 40 Clinical Trial Overview of Merck & Co., Inc. 40 Amgen Inc. 41 Clinical Trial Overview of Amgen Inc. 41 Biogen Idec Inc. 42 Clinical Trial Overview of Biogen Idec Inc. 42 Clinical Trial Overview of Top Universities / Institutes / Hospitals 43 Weill Cornell Medical College 43 Clinical Trial Overview of Weill Cornell Medical College 43 Duke University 44 Clinical Trial Overview of Duke University 44 City of Hope National Medical Center 45 Clinical Trial Overview of City of Hope National Medical Center 45 University of California, San Francisco 46 Clinical Trial Overview of University of California, San Francisco 46 H. Lee Moffitt Cancer Center & Research Institute 47 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 47 University of California, Los Angeles 48 Clinical Trial Overview of University of California, Los Angeles 48 Wake Forest University 49 Clinical Trial Overview of Wake Forest University 49 Fred Hutchinson Cancer Research Center 50 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 50 European Organization for Research and Treatment of Cancer 51 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 51 University of Heidelberg 52 Clinical Trial Overview of University of Heidelberg 52 Memorial Sloan Kettering Cancer Center 53 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 53 Dartmouth-Hitchcock Medical Center 54 Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 54 Northwestern University 55 Clinical Trial Overview of Northwestern University 55 University of Colorado 56 Clinical Trial Overview of University of Colorado 56 Haukeland University Hospital 57 Clinical Trial Overview of Haukeland University Hospital 57 Case Comprehensive Cancer Center 58 Clinical Trial Overview of Case Comprehensive Cancer Center 58 Dana-Farber Cancer Institute 59 Clinical Trial Overview of Dana-Farber Cancer Institute 59 Roswell Park Cancer Institute 60 Clinical Trial Overview of Roswell Park Cancer Institute 60 Hopitaux Universitaires de Geneve 61 Clinical Trial Overview of Hopitaux Universitaires de Geneve 61 Drexel University 62 Clinical Trial Overview of Drexel University 62 Five Key Clinical Profiles 63 Appendix 87 Abbreviations 87 Definitions 87 Research Methodology 88 Secondary Research 88 About GlobalData 89 Contact Us 89 Disclaimer 89 Source 90 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Anaplastic Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 11 Anaplastic Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Anaplastic Astrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Anaplastic Astrocytoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14 Anaplastic Astrocytoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15 Anaplastic Astrocytoma Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Anaplastic Astrocytoma Therapeutics Clinical Trials, G7 Countries, 2012* 17 Anaplastic Astrocytoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Anaplastic Astrocytoma Therapeutics Clinical Trials, E7 Countries, 2012* 19 Anaplastic Astrocytoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Anaplastic Astrocytoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24 Anaplastic Astrocytoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 24 Anaplastic Astrocytoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by INSYS Therapeutics, Inc., 2012* 32 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Antisense Pharma GmbH, 2012* 33 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2012* 34 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boneca Corporation, 2012* 35 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Advantagene, Inc., 2012* 36 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012* 37 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012* 38 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2012* 39 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 40 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 41 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2012* 42 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 43 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 44 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 45 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 46 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 47 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 48 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 49 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 50 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 51 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012* 52 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 53 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2012* 54 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 55 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 56 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2012* 57 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 58 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 59 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 60 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012* 61 Anaplastic Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Drexel University, 2012* 62 List of Figures Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Anaplastic Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 11 Anaplastic Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Anaplastic Astrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Anaplastic Astrocytoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15 Anaplastic Astrocytoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Anaplastic Astrocytoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Anaplastic Astrocytoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Anaplastic Astrocytoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Anaplastic Astrocytoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29 Anaplastic Astrocytoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 31 GlobalData Methodology 88 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
